LncRNA 005620

ncRNA information

ncRNA name

LncRNA 005620

Specific or universal ncRNAs

Specific ncRNAs

Class

Long noncoding RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

ITGB1

Cancer information

Cancer name

Triple-Negative Breast Cancer

Cancer site

qRT-PCR,Western blot

Treatment information

Treatment type

Chemotherapy

Drug

Epirubicin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Novel Long Noncoding RNA 005620 Induces Epirubicin Resistance in Triple-Negative Breast Cancer by Regulating ITGB1 Expression

Tissue resource

primary cancer tissue and adjacent nonā€cancerous tissue samples

human triple-negative breast cancer cell lines MDA-MB-231

Experiment

None


Institute

the Affiliated Obstetrics and Gynaecology Hospital of Nanjing Medical University

Chinese Type Culture Collection, Chinese Academy of Sciences

Country

China

China

Continent

Asia

Asia